α-Galactosylceramide Promotes Killing of Listeria monocytogenes within the Macrophage Phagosome through Invariant NKT-Cell Activation

α-Galactosylceramide (α-GalCer) has been exploited for the treatment of microbial infections. Although amelioration of infection by α-GalCer involves invariant natural killer T (iNKT)-cell activation, it remains to be determined whether macrophages (Mφ) participate in the control of microbial pathog...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Emoto, Masashi, Yoshida, Tomomi, Fukuda, Toshio, Kawamura, Ikuo, Mitsuyama, Masao, Kita, Eiji, Hurwitz, Robert, Kaufmann, Stefan H. E., Emoto, Yoshiko
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology (ASM) 2010
Matèries:
Host Response and Inflammation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2876567/
https://ncbi.nlm.nih.gov/pubmed/20351146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/IAI.01441-09
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars